Rac1 Activity Is Modulated by Huntingtin and Dysregulated in Models of Huntington's Disease.


Journal

Journal of Huntington's disease
ISSN: 1879-6400
Titre abrégé: J Huntingtons Dis
Pays: Netherlands
ID NLM: 101589965

Informations de publication

Date de publication:
2019
Historique:
pubmed: 31 12 2018
medline: 13 3 2020
entrez: 31 12 2018
Statut: ppublish

Résumé

Previous studies suggest that Huntingtin, the protein mutated in Huntington's disease (HD), is required for actin based changes in cell morphology, and undergoes stimulus induced targeting to plasma membranes where it interacts with phospholipids involved in cell signaling. The small GTPase Rac1 is a downstream target of growth factor stimulation and PI 3-kinase activity and is critical for actin dependent membrane remodeling. To determine if Rac1 activity is impaired in HD or regulated by normal Huntingtin. Analyses were performed in differentiated control and HD human stem cells and HD Q140/Q140 knock-in mice. Biochemical methods included SDS-PAGE, western blot, immunoprecipitation, affinity chromatography, and ELISA based Rac activity assays. Basal Rac1 activity increased following depletion of Huntingtin with Huntingtin specific siRNA in human primary fibroblasts and in human control neuron cultures. Human cells (fibroblasts, neural stem cells, and neurons) with the HD mutation failed to increase Rac1 activity in response to growth factors. Rac1 activity levels were elevated in striatum of 1.5-month-old HD Q140/Q140 mice and in primary embryonic cortical neurons from HD mice. Affinity chromatography analysis of striatal lysates showed that Huntingtin is in a complex with Rac1, p85α subunit of PI 3-kinase, and the actin bundling protein α-actinin and interacts preferentially with the GTP bound form of Rac1. The HD mutation reduced Huntingtin interaction with p85α. These findings suggest that Huntingtin regulates Rac1 activity as part of a coordinated response to growth factor signaling and this function is impaired early in HD.

Sections du résumé

BACKGROUND
Previous studies suggest that Huntingtin, the protein mutated in Huntington's disease (HD), is required for actin based changes in cell morphology, and undergoes stimulus induced targeting to plasma membranes where it interacts with phospholipids involved in cell signaling. The small GTPase Rac1 is a downstream target of growth factor stimulation and PI 3-kinase activity and is critical for actin dependent membrane remodeling.
OBJECTIVE
To determine if Rac1 activity is impaired in HD or regulated by normal Huntingtin.
METHODS
Analyses were performed in differentiated control and HD human stem cells and HD Q140/Q140 knock-in mice. Biochemical methods included SDS-PAGE, western blot, immunoprecipitation, affinity chromatography, and ELISA based Rac activity assays.
RESULTS
Basal Rac1 activity increased following depletion of Huntingtin with Huntingtin specific siRNA in human primary fibroblasts and in human control neuron cultures. Human cells (fibroblasts, neural stem cells, and neurons) with the HD mutation failed to increase Rac1 activity in response to growth factors. Rac1 activity levels were elevated in striatum of 1.5-month-old HD Q140/Q140 mice and in primary embryonic cortical neurons from HD mice. Affinity chromatography analysis of striatal lysates showed that Huntingtin is in a complex with Rac1, p85α subunit of PI 3-kinase, and the actin bundling protein α-actinin and interacts preferentially with the GTP bound form of Rac1. The HD mutation reduced Huntingtin interaction with p85α.
CONCLUSIONS
These findings suggest that Huntingtin regulates Rac1 activity as part of a coordinated response to growth factor signaling and this function is impaired early in HD.

Identifiants

pubmed: 30594931
pii: JHD180311
doi: 10.3233/JHD-180311
pmc: PMC6398565
doi:

Substances chimiques

HTT protein, human 0
Huntingtin Protein 0
Microfilament Proteins 0
Nerve Tissue Proteins 0
Neuropeptides 0
RAC1 protein, human 0
Rac1 protein, mouse 0
rac1 GTP-Binding Protein EC 3.6.5.2

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

53-69

Subventions

Organisme : NINDS NIH HHS
ID : R01 NS100529
Pays : United States
Organisme : NIH HHS
ID : S10 OD020012
Pays : United States

Références

Neuron. 2013 May 8;78(3):483-97
pubmed: 23664615
Nat Rev Mol Cell Biol. 2007 Jan;8(1):37-48
pubmed: 17183359
Hum Mol Genet. 2011 May 15;20(10):1937-51
pubmed: 21355047
PLoS Genet. 2007 May 11;3(5):e82
pubmed: 17500595
Mol Cell Biol. 2005 Jun;25(12):5106-18
pubmed: 15923627
J Biol Chem. 1997 Mar 28;272(13):8121-4
pubmed: 9079622
Hum Mol Genet. 2015 Dec 20;24(25):7265-85
pubmed: 26464483
Cell. 1993 Mar 26;72(6):971-83
pubmed: 8458085
J Clin Invest. 2014 Oct;124(10):4411-28
pubmed: 25180603
J Neurosci. 1991 Dec;11(12):3877-87
pubmed: 1836019
Mol Neurobiol. 2019 Feb;56(2):935-953
pubmed: 29804232
Cell Stem Cell. 2012 Aug 3;11(2):264-78
pubmed: 22748968
Mol Neurodegener. 2010 Dec 14;5:58
pubmed: 21156064
J Neurochem. 2009 Sep;110(5):1585-97
pubmed: 19566678
J Clin Invest. 2012 Dec;122(12):4737-47
pubmed: 23160193
FASEB J. 2009 May;23(5):1347-57
pubmed: 19126596
Neuron. 2007 Nov 21;56(4):640-56
pubmed: 18031682
J Neurosci. 2014 Jul 9;34(28):9455-72
pubmed: 25009276
J Neurosci. 2005 Mar 30;25(13):3379-88
pubmed: 15800193
Mol Cell Neurosci. 2012 May;50(1):70-81
pubmed: 22508027
Cell. 1995 Jun 2;81(5):811-23
pubmed: 7774020
J Cell Biol. 2000 Aug 7;150(3):627-42
pubmed: 10931873
Mol Cell Biol. 2008 Sep;28(17):5196-208
pubmed: 18573880
J Neurosci Res. 2010 Jan;88(1):179-90
pubmed: 19642201
Cell Cycle. 2012 May 15;11(10):2006-21
pubmed: 22580459
Cell. 1989 Apr 7;57(1):167-75
pubmed: 2467744
Neuroreport. 2012 Jan 4;23(1):10-5
pubmed: 22045254
J Cell Sci. 2013 Jan 1;126(Pt 1):263-73
pubmed: 23132927
Neurology. 1991 Jul;41(7):1117-23
pubmed: 1829794
Proc Natl Acad Sci U S A. 2007 Oct 23;104(43):17204-9
pubmed: 17940007
Exp Cell Res. 1999 Nov 25;253(1):239-54
pubmed: 10579926
J Biol Chem. 2005 Oct 28;280(43):36464-73
pubmed: 16085648
J Biol Chem. 2012 Jun 22;287(26):21599-614
pubmed: 22556411
Cell. 1999 Aug 20;98(4):537-46
pubmed: 10481917
Mol Ther Nucleic Acids. 2015 Dec 01;4:e266
pubmed: 26623938
J Cell Sci. 1995 Jan;108 ( Pt 1):225-33
pubmed: 7738099
Cell Mol Life Sci. 2008 Sep;65(17):2688-701
pubmed: 18488141
Stem Cell Res. 2013 May;10(3):417-427
pubmed: 23474892
Cell. 2000 Oct 13;103(2):211-25
pubmed: 11057895
J Biol Chem. 2014 Mar 7;289(10):6709-26
pubmed: 24407293
Biol Cell. 2007 Aug;99(8):455-64
pubmed: 17428196
Cell Microbiol. 2002 Jan;4(1):19-28
pubmed: 11856170
Neuron. 2016 Mar 2;89(5):910-26
pubmed: 26938440
J Biol Chem. 2006 Jul 7;281(27):18652-9
pubmed: 16698790
J Neurosci. 2008 Nov 19;28(47):12368-82
pubmed: 19020030
PLoS One. 2010 Feb 04;5(2):e9053
pubmed: 20140226
J Biol Chem. 2002 Feb 22;277(8):6703-7
pubmed: 11733534
EMBO J. 2004 Feb 25;23(4):749-59
pubmed: 14765121
EMBO J. 1998 Dec 1;17(23):6932-41
pubmed: 9843499
Oncogene. 1990 May;5(5):769-72
pubmed: 2189110
Cell Stem Cell. 2012 Aug 3;11(2):253-63
pubmed: 22748967
Trends Biochem Sci. 2003 Aug;28(8):425-33
pubmed: 12932731
PLoS Genet. 2012;8(11):e1003042
pubmed: 23209424
Brain Res. 1999 Feb 13;818(2):468-79
pubmed: 10082833
Oncogene. 1991 May;6(5):863-6
pubmed: 1905006
Neuron. 1995 May;14(5):1075-81
pubmed: 7748555
Cell. 2004 Jan 23;116(2):167-79
pubmed: 14744429
Science. 1995 Jul 21;269(5222):407-10
pubmed: 7618107
Nature. 1999 Feb 18;397(6720):621-5
pubmed: 10050856
Nature. 1996 Feb 29;379(6568):837-40
pubmed: 8587609
PLoS Biol. 2005 Sep;3(9):e283
pubmed: 16086633
PLoS One. 2014 Jul 09;9(7):e101770
pubmed: 25007055
Cell. 1997 May 2;89(3):457-67
pubmed: 9150145
Cell. 1997 Aug 8;90(3):549-58
pubmed: 9267034
J Biol Chem. 1995 Jul 28;270(30):17656-9
pubmed: 7629060
J Biol Chem. 1999 May 7;274(19):13198-204
pubmed: 10224076
Neuron. 2012 Jul 12;75(1):41-57
pubmed: 22794259
Nat Genet. 2000 Nov;26(3):300-6
pubmed: 11062468
Mol Cell. 2009 Nov 13;36(3):512-24
pubmed: 19917258
J Biol Chem. 1997 Aug 15;272(33):20384-8
pubmed: 9252344
Sci Rep. 2018 May 22;8(1):8000
pubmed: 29789657
Hum Mol Genet. 2013 Mar 15;22(6):1112-31
pubmed: 23223017
Nat Genet. 1995 Oct;11(2):155-63
pubmed: 7550343
Science. 1985 Feb 15;227(4688):770-3
pubmed: 3155875
J Neurosci. 2002 Sep 15;22(18):8266-76
pubmed: 12223581
Development. 2015 Apr 1;142(7):1375-86
pubmed: 25804741

Auteurs

Adelaide Tousley (A)

Department of Neurology, Laboratory of Cellular Neurobiology, Massachusetts General Hospital, Charlestown, MA, USA.

Maria Iuliano (M)

Department of Neurology, Laboratory of Cellular Neurobiology, Massachusetts General Hospital, Charlestown, MA, USA.

Elizabeth Weisman (E)

Department of Neurology, Laboratory of Cellular Neurobiology, Massachusetts General Hospital, Charlestown, MA, USA.

Ellen Sapp (E)

Department of Neurology, Laboratory of Cellular Neurobiology, Massachusetts General Hospital, Charlestown, MA, USA.

Ningzhe Zhang (N)

Buck Institute for Research on Aging, Novato, CA, USA.

Petr Vodicka (P)

Department of Neurology, Laboratory of Cellular Neurobiology, Massachusetts General Hospital, Charlestown, MA, USA.

Jonathan Alexander (J)

Department of Neurology, Laboratory of Cellular Neurobiology, Massachusetts General Hospital, Charlestown, MA, USA.

Hubert Aviolat (H)

Department of Neurology, Laboratory of Cellular Neurobiology, Massachusetts General Hospital, Charlestown, MA, USA.

Leah Gatune (L)

Department of Neurology, Laboratory of Cellular Neurobiology, Massachusetts General Hospital, Charlestown, MA, USA.

Patrick Reeves (P)

Department of Neurology, Laboratory of Cellular Neurobiology, Massachusetts General Hospital, Charlestown, MA, USA.

Xueyi Li (X)

Department of Neurology, Laboratory of Cellular Neurobiology, Massachusetts General Hospital, Charlestown, MA, USA.

Anastasia Khvorova (A)

RNA Therapeutics Institute, University of Massachusetts Medical School, Worcester, MA, USA.

Lisa M Ellerby (LM)

Buck Institute for Research on Aging, Novato, CA, USA.

Neil Aronin (N)

RNA Therapeutics Institute, University of Massachusetts Medical School, Worcester, MA, USA.
Department of Medicine and Cell Biology, University of Massachusetts Medical School, Worcester, MA, USA.

Marian DiFiglia (M)

Department of Neurology, Laboratory of Cellular Neurobiology, Massachusetts General Hospital, Charlestown, MA, USA.

Kimberly B Kegel-Gleason (KB)

Department of Neurology, Laboratory of Cellular Neurobiology, Massachusetts General Hospital, Charlestown, MA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH